Health Policy

Could a smartphone app help stop the next polio outbreak in Pakistan?

Could a smartphone app help stop the next polio outbreak in Pakistan?

November 12, 2015

By Michael Callen - The Conversation

Between 1988 and 2013, the number of cases of polio worldwide plummeted from 350,000 to 406. The number of countries in which the disease was endemic also went down, from 125 to three. The world seemed on the verge of eradicating the disease once and for all.

Cash Transfers to Indonesia's Poor Don't Discourage Work

Cash Transfers to Indonesia's Poor Don't Discourage Work

October 31, 2015

By Rema Hanna and Benjamin Olken - Jakarta Globe 

Around the world, there are often contentious debates on whether or not to provide social safety net programs to the poor. Critics often paint a portrait of the poor as lazy, refusing to work in order to receive government handouts, wasting valuable tax-payer funds on for example alcohol and cigarettes, rather than feeding and clothing children.

These cheap, clean stoves were supposed to save millions of lives. What happened?

These cheap, clean stoves were supposed to save millions of lives. What happened?

October 29, 2015

By Marc Gunther - The Washington Post

The best cookstoves burning clean fuels won’t protect poor families from disease if those who use them continue to cook over open fires as well — which many do. “They’re not the big solution, unfortunately, that we thought they were going to be,” says Rema Hanna, a Harvard economist who led “Up in Smoke,” the most extensive field study to date on this subject. 

Baker: Lowell General Hospital an industry model

Baker: Lowell General Hospital an industry model

October 6, 2015

By Andy Metzger - Lowell Sun

While extolling the importance of competition, Amitabh Chandra, professor of social policy and director of health-policy research at Harvard's Kennedy School of Government, included price transparency with management of population health, and wellness programs as ideas that should elicit skepticism.

Baker Outlines His Take on Healthcare Costs

Baker Outlines His Take on Healthcare Costs

October 5, 2015

By Andy Metzger - State House News Service

While extolling the importance of competition, Harvard Kennedy School professor Amitabh Chandra included price transparency with management of population health, and wellness programs as ideas that should elicit skepticism. "We have to be extremely skeptical of all the something-for-nothing remedies," Chandra told the Health Policy Commission Monday... 

State Capitol Briefs - Lunch Edition

State Capitol Briefs - Lunch Edition

October 5, 2015

State House News Service

Amitabh Chandra, a health policy expert and economist, told the commission that innovation in the sector will be spurred by new patients receiving coverage through the Affordable Care Act, and that is likely to drive up costs. Chandra also warned against embracing "snake oil" cures for cost growth, which he identified as transparency tools and spending on wellness, which he said is beneficial but not necessarily a cost-saver.

Baker tips cap to Lowell General Hospital at health-costs hearing

Baker tips cap to Lowell General Hospital at health-costs hearing

October 5, 2015

By State House News Service - Lowell Sun

Amitabh Chandra, a health-policy expert and economist, told the commission that innovation in the sector will be spurred by new patients receiving coverage through the Affordable Care Act, and that is likely to drive up costs. Chandra also warned against embracing "snake oil" cures for cost growth, which he identified as transparency tools and spending on wellness, which he said is beneficial but not necessarily a cost-saver. "There's really no substitute to paying less or doing less," Chandra said.

Asim Khwaja on Evidence for Policy Design

Asim Khwaja on Evidence for Policy Design

September 29, 2015

By Doug Gavel - Harvard Kennedy School

When development economists conduct research, one of the goals is to help practitioners and policymakers create better policies in countries struggling with a host of educational, political, and financial challenges. Asim Ijaz Khwaja is the Sumitomo-Foundation for Advanced Studies on International Development Professor of International Finance and Development at Harvard Kennedy School, and co-director of Evidence for Policy Design (EPoD) at the Center for International Development.

Greedy Pharma CEO Cancels 5,000% Price Hike -- But He Didn't Fix The Real Problem

Greedy Pharma CEO Cancels 5,000% Price Hike -- But He Didn't Fix The Real Problem

September 22, 2015

By Dan Diamond - Forbes

Harvard’s Amitabh Chandra tells the New York Times that Clinton’s proposal to force pharma companies to reinvest profits into R&D is “astonishingly naïve”; there’s no evidence that pharma firms aren’t doing enough research, and pushing them to spend more upfront would seem to do little to lower the actual costs of drugs. 

Why Some Policy Experts Question Clinton’s Plan to Contain Drug Costs

Why Some Policy Experts Question Clinton’s Plan to Contain Drug Costs

September 22, 2015

By Margot Sanger-Katz - The Upshot - The New York Times

“This is an astonishingly naïve approach,” said Amitabh Chandra, a professor of public policy at Harvard University, in an email. He argues that the plan could encourage wasteful research spending without necessarily doing much about the prices charged for medications.